Genomic and immunological characterization between primary and recurrent breast cancer.

被引：0
|
作者：
Liu, Danni
Zhang, Jing
Peisu, Suo
Chen, Shifu
Peng, Xiufan
机构：
[1] HaploX Biotechnol, Shenzhen, Peoples R China
[2] Clifford Hosp, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12553
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer
    Meric-Bernstam, Funda
    Frampton, Garrett M.
    Ferrer-Lozano, Jaime
    Yelensky, Roman
    Perez-Fidalgo, Jose A.
    Wang, Ying
    Palmer, Gary A.
    Ross, Jeffrey S.
    Miller, Vincent A.
    Su, Xiaoping
    Eroles, Pilar
    Antonio Barrera, Juan
    Burgues, Octavio
    Lluch, Ana M.
    Zheng, Xiaofeng
    Sahin, Aysegul
    Stephens, Philip J.
    Mills, Gordon B.
    Cronin, Maureen T.
    Gonzalez-Angulo, Ana M.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) : 1382 - 1389
  • [2] Prognostic impact of discordance of ER and PR between primary and recurrent breast cancer.
    Li Nani
    Cao Wenming
    Wang Xiao Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Lymphoscintigraphy in Breast Cancer. Is there a difference in primary versus recurrent disease?
    Pereira, B.
    Soeiro, P.
    Dias, P.
    Oliveira, A.
    Fernandes, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S596 - S596
  • [4] Genomic characterization of a region commonly deleted in sporadic breast cancer.
    Lewis, TB
    Wu, C
    Gloeckner, G
    deJong, P
    Rosenthal, A
    Tischfield, J
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A135 - A135
  • [5] Changing ER, PgR, and HER2 status between primary and recurrent breast cancer.
    Matsumoto, Akiko
    Takahashi, Maiko
    Hayashida, Tetsu
    Hirose, Shigemichi
    Jinno, Hiromitsu
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [6] Immunological differences between primary and metastatic breast cancer
    Szekely, Borbala
    Bossuyt, Veerle
    Li, Xiaotong
    Baine, Marina
    Silber, Andrea
    Sanft, Tara
    Hofstatter, Erin
    Mougalian, Sarah
    Baghwagar, Sanaea
    Neumeister, Veronique
    Pelekanou, Vasiliki
    Hatzis, Christos
    Pusztai, Lajos
    CANCER RESEARCH, 2018, 78 (04)
  • [7] Immunological differences between primary and metastatic breast cancer
    Szekely, B.
    Bossuyt, V.
    Li, X.
    Wali, V. B.
    Patwardhan, G. A.
    Frederick, C.
    Silber, A.
    Park, T.
    Harigopal, M.
    Pelekanou, V.
    Zhang, M.
    Yan, Q.
    Rimm, D. L.
    Bianchini, G.
    Hatzis, C.
    Pusztai, L.
    ANNALS OF ONCOLOGY, 2018, 29 (11) : 2232 - 2239
  • [8] Genomic Characterization of Primary Invasive Lobular Breast Cancer
    Desmedt, Christine
    Zoppoli, Gabriele
    Gundem, Gunes
    Pruneri, Giancarlo
    Larsimont, Denis
    Fornili, Marco
    Fumagalli, Debora
    Brown, David
    Rothe, Francoise
    Vincent, Delphine
    Kheddoumi, Naima
    Rouas, Ghizlane
    Majjaj, Samira
    Brohee, Sylvain
    Van Loo, Peter
    Maisonneuve, Patrick
    Salgado, Roberto
    Van Brussel, Thomas
    Lambrechts, Diether
    Bose, Ron
    Metzger, Otto
    Galant, Christine
    Bertucci, Francois
    Piccart-Gebhart, Martine
    Viale, Giuseppe
    Biganzoli, Elia
    Campbell, Peter J.
    Sotiriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (16) : 1872 - +
  • [9] Comparative study of receptor expression diversity between primary and recurrent lesions in patients with metastatic breast cancer.
    Erdem, Gokmen Umut
    Ozdemir, Nuriye
    Sahin, Suleyman
    Demirci, Nebi Serkan
    Karatas, Fatih
    Bozkaya, Yakup
    Aytekin, Aydin
    Sever, Ali Riza
    Zengin, Nurullah
    Altundag, Mustafa Kadri
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] THE GENOMIC AND IMMUNOLOGICAL CHARACTERIZATION OF COLORECTAL AND BREAST CANCER STEM CELLS: IMPLICATIONS FOR CANCER IMMUNOTHERAPY
    Gopinath, N.
    Gupta, I.
    Hussein, O.
    Turdo, A.
    Chin-Smith, E.
    Metthiew, R.
    Manjunath, H. Shobha
    Toufiq, M.
    Tomei, S.
    Todaro, M.
    Stassi, G.
    Skvortsova, I.
    Maccalli, C.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A41 - A42
12345